Thursday, May 26, 2016

AMI Begins Participation in World’s Largest Brain Amyloid Scanning Research Study

Imaging Dementia - Evidence for Amyloid Scanning at Atlantic Medical Imaging

Nation-wide IDEAS Study to determine clinical value of PET scans in Alzheimer’s disease diagnosis.

Atlantic Medical Imaging (AMI) has been selected to participate in the world’s largest brain amyloid scanning research study. The IDEAS (Imaging Dementia – Evidence for Amyloid Scanning) Study will follow more than 18,000 Medicare patients nation-wide to evaluate the clinical value of a brain positron emission tomography (PET) scan to detect the hallmark brain amyloid accumulation of Alzheimer’s disease in diagnosing and managing treatment of patients age 65 and older with mild cognitive impairment (MCI) or dementia of uncertain cause. Information from this scan can help exclude underlying Alzheimer’s disease, and may help guide patient management.